NASDAQ
LAVA Therapeutics N.V. (LVTX) has a current ratio of 4.40x as of Monday, May 25, 2026. This represents a 36.27% decrease compared to its 12-month average of 6.91x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.